Management of opioid-induced constipation in pregnancy: A concise review with emphasis on the PAMORAs

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 6, 2015, Pages 615-619

  Li, Z ^a   Pergolizzi, J V ^b,c,d   Huttner, R P ^e   Zampogna, G ^f   Breve, F ^a   Raffa, R B ^a  

^a TEMPLE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Pain Center   (United States)

^e Women's Health Center of Hunterdon County   (United States)

^f NEMA Research   (United States)

Author keywords

constipation management; opioid induced constipation during pregnancy; peripheral mu opioid receptor antagonists (PAMORAs)

Indexed keywords

BISACODYL; GUAR GUM; ISPAGULA; LACTULOSE; LAXATIVE; LUBIPROSTONE; MACROGOL; MAGNESIUM OXIDE; METHYLCELLULOSE; MU OPIATE RECEPTOR ANTAGONIST; NALOXEGOL; PERIPHERALLY ACTING MU OPIOID RECEPTOR ANTAGONIST; POLYCARBOPHIL; SENNA EXTRACT; SORBITOL; UNCLASSIFIED DRUG; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL DISEASE; ABDOMINAL FULLNESS; ABDOMINAL PAIN; BLOATING; CONSTIPATION; DEHYDRATION; DIARRHEA; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; FLATULENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL IRRITATION; HUMAN; HYPERMAGNESEMIA; LIFESTYLE MODIFICATION; LUNG EDEMA; MELANOSIS; MELANOSIS COLI; MULTICENTER STUDY (TOPIC); NAUSEA; OPIOID INDUCED CONSTIPATION; PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM HEMORRHAGE; REVIEW; UNSPECIFIED SIDE EFFECT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; METABOLISM;

ANALGESICS, OPIOID; ANIMALS; CONSTIPATION; FEMALE; HUMANS; LAXATIVES; PREGNANCY; RECEPTORS, OPIOID, MU;

EID: 84983175047     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12331     Document Type: Review

References (30)

1. Coyne KS, Margolis MK, Yeomans K, et al,. Opioid-induced constipation among patients with chronic non-cancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time. Pain Med, 2015; 16: 1551-1565.
2. Wan Y, Corman S, Gao X, et al,. Economic burden of opioid-induced constipation among long-term opioid users with non-cancer pain. Am Health Drug Benefits, 2015; 8: 93-102.
3. Kumar L, Barker C, Emmanuel A,. Opioid-induced constipation: pathophysiology, clinical consequences, and management. Gastroenterol Res Pract, 2014; 141737: 6.
4. Siemens W, Gaertner J, Becker G,. Advances in pharmacotherapy for opioid-induced constipation a systematic review. Expert Opin Pharmacother, 2015; 16: 515-532.
5. Levy N, Lemberg E, Sharf M, et al,. Bowel habit in pregnancy. Digestion, 1971; 4: 216-222.
6. Bonapace ES Jr, Fisher RS,. Constipation and diarrhea in pregnancy. Gastroenterol Clin North Am, 1998; 27: 197-211.
7. Shin GH, Toto EL, Schey R, et al,. Pregnancy and postpartum bowel changes: constipation and fecal incontinence. Am J Gastroenterol, 2015; 110: 521-529.
8. Trottier M, Erebara A, Bozzo P, et al,. Treating constipation during pregnancy. Can Fam Physician, 2012; 58: 836-838.
9. Derbyshire EJ, Davies J, Detmar P, et al,. Changes in bowel function: pregnancy and the puerperium. Dig Dis Sci, 2007; 52: 324-328.
10. Jewell D, Young G., Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev, 2001;(2): CD001142.
11. Anderson AS, Whichelow MJ,. Constipation during pregnancy: dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr, 1985; 39: 202-207.
12. Prather CM,. Pregnancy-related constipation. Curr Gastroenterol Rep, 2004; 6: 402-404.
13. Kurz A, Sessler DI,. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs, 2003; 63: 649-671.
14. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A,. Myths and misconceptions about chronic constipation. Am J Gastroenterol, 2005; 100: 232-242.
15. West L, Warren J, Cutts T,. Diagnosis and management of irritable bowel syndrome, constipation, and diarrhea in pregnancy. Gastroenterol Clin North Am, 1992; 21: 793-802.
16. Gyawali B, Hayashi N, Tsukuura H, et al,. Opioid-induced constipation. Scand J Gastroenterol, 2015; 50: 1331-1338.
17. Holzer P,. New approaches to the treatment of opioid-induced constipation. Eur Rev Med Pharmacol Sci, 2008; 12: 19-27.
18. Rauck R,. Treatment of opioid-induced constipation: focus on the peripheral mu-opioid receptor antagonist methylnaltrexone. Drugs, 2013; 73: 1297-1306.
19. Thomas J, Karver S, Cooney GA, et al,. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med, 2008; 358: 2332-2343.
20. Michna E, Blonsky ER, Schulman S, et al,. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. J Pain, 2011; 12: 554-562.
21. Leonard J, Baker DE,. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain. Ann Pharmacother, 2015; 49: 360-365.
22. Eldon MA, Song D, Neumann TA, et al,. NKTR-118 (oral PEG-naloxol), A PEGylated Derivative of Naloxone: Demonstration of Selective Peripheral Opioid Antagonism After Oral Administration in Preclinical Models. Poster presented at: the American Academy of Pain Management 18th Annual Clinical Meeting; September 17-30, 2007; Las Vegas, NV.
23. GarnockJones KP,. Naloxegol: a review of its use in patients with opioid-induced constipation. Drugs, 2015; 75: 419-425.
24. Chey WD, Webster L, Sostek M, et al,. Naloxegol for opioid-induced constipation in patients with non-cancer pain. N Engl J Med, 2014; 370: 2387-2396.
25. Wong BS, Camilleri M,. Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opin Pharmacother, 2011; 12: 983-990.
26. Fei G, Raehal K, Liu S, et al,. Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse. J Pharmacol Exp Ther, 2010; 334: 333-340.
27. Cryer BL,. A phase 3, randomized, double-blind, placebo-controlled clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction in patients with chronic, non-cancer pain. Gastroenterology, 2010; 138: S-129.
28. Portalatin M, Winstead N,. Medical management of constipation. Clin Colon Rectal Surg, 2012; 25: 12-19.
29. Ford AC, Brenner DM, Schoenfeld PS, et al,. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis. Am J Gastroenterol, 2013; 108: 1566-1574.
30. Leppert W,. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des, 2015; 9: 2215-2231.